Hikma appoints Teva executive as chief transformation officer

Hikma Pharmaceuticals PLC (Hikma) has appointment Henriette Nielsen to the newly created role of chief transformation officer.

In this role, Henriette will be responsible for leading a number of initiatives across Hikma’s global operations to improve operational efficiency and ensure that Hikma achieves its strategic objectives. She will join Hikma’s executive committee and will report directly to Siggi Olafsson, Hikma’s chief executive officer. Her appointment is effective from 4 June 2018.

Henriette joins Hikma from Teva Pharmaceuticals USA, where she was most recently senior vice president, chief transformation officer, global marketing & portfolio. Her previous experience includes founder of System Matters, a healthcare and impact investing consultancy, and General Counsel and EVP at Actavis Group. She also held senior roles at Alpharma, Netdoktor and Kromann Reumert.

Read more: Hikma appoints Teva executive as chief transformation officer